What is alkaptonuria? The rare disease that turns your pee black
Alkaptonuria is an unusual disorder caused by a defect in protein metabolism.
Get the world’s most fascinating discoveries delivered straight to your inbox.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Delivered Daily
Daily Newsletter
Sign up for the latest discoveries, groundbreaking research and fascinating breakthroughs that impact you and the wider world direct to your inbox.
Once a week
Life's Little Mysteries
Feed your curiosity with an exclusive mystery every week, solved with science and delivered direct to your inbox before it's seen anywhere else.
Once a week
How It Works
Sign up to our free science & technology newsletter for your weekly fix of fascinating articles, quick quizzes, amazing images, and more
Delivered daily
Space.com Newsletter
Breaking space news, the latest updates on rocket launches, skywatching events and more!
Once a month
Watch This Space
Sign up to our monthly entertainment newsletter to keep up with all our coverage of the latest sci-fi and space movies, tv shows, games and books.
Once a week
Night Sky This Week
Discover this week's must-see night sky events, moon phases, and stunning astrophotos. Sign up for our skywatching newsletter and explore the universe with us!
Join the club
Get full access to premium articles, exclusive features and a growing list of member rewards.
Disease name: Alkaptonuria, also known as "black urine disease"
Affected populations: The exact prevalence of alkaptonuria worldwide is unknown. However, estimates suggest that the disease affects between 1 in 250,000 and 1 in 1 million people in the U.S. More than 1,000 cases of alkaptonuria have been reported in the medical literature. Individuals from any group can potentially develop the disease, regardless of their sex, race or other factors. However, alkaptonuria is a recessive genetic disorder, meaning people will only develop it if they inherit two faulty copies of a specific gene — one from each of their parents.
Causes: People with alkaptonuria are unable to fully break down all the building blocks of proteins that they consume or that their body makes. This is because a mutation in a gene called homogentisate 1,2-diooxygenase (HGD) causes an enzyme that normally does the job to malfunction. Consequently, a chemical called homogentisic acid accumulates in different tissues in the body, especially in connective tissues, such as cartilage.
Related: Finally, we know why pee is yellow
Symptoms: One of the earliest signs that someone has alkaptonuria is dark stains in their diapers as babies, because the homogentisic acid in their urine turns black upon exposure to air.
Besides dark urine, people with alkaptonuria often have no other noticeable symptoms of the disease until they are in their late 20s or early 30s.
Over time, homogentisic acid continues to build up in a person's tissues, staining those tissues a slate blue or black color and eventually weakening and damaging them. This can lead to severe deformities in the joints and spine, as well as organ dysfunction, including issues with the kidneys and heart. Symptoms of alkaptonuria tend to be more severe and come on sooner in males than in females.
Get the world’s most fascinating discoveries delivered straight to your inbox.
Although patients with alkaptonuria tend to have a normal life expectancy, the disease can markedly impact their quality of life.
Treatments: There is currently no cure for alkaptonuria, but scientists are studying the potential use of a drug called nitisinone to slow the progression of the disease. Affected individuals can also take steps to manage their symptoms, including taking painkillers and exercising regularly to help strengthen their joints. Adopting a low-protein diet can also help some patients.
Around half of patients with alkaptonuria will require hip, knee or shoulder joint replacement, usually by the age of 50 or 60.
This article is for informational purposes only and is not meant to offer medical advice.

Emily is a health news writer based in London, United Kingdom. She holds a bachelor's degree in biology from Durham University and a master's degree in clinical and therapeutic neuroscience from Oxford University. She has worked in science communication, medical writing and as a local news reporter while undertaking NCTJ journalism training with News Associates. In 2018, she was named one of MHP Communications' 30 journalists to watch under 30.
You must confirm your public display name before commenting
Please logout and then login again, you will then be prompted to enter your display name.
